Total Funding
22
27
Total FundingPost-IPO Debt raised
Growth Score 22 in past quarter
0 pts
Heat Score 27 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
187357
Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.
- Nora E Brennan: CFOPast Role: Fore Biotherapeutics, Chief Financial Officer
About the Company
Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology. It has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development.